Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 11, 2016 - Issue
Submit an article Journal homepage
80
Views
15
CrossRef citations to date
0
Altmetric
Methodology

Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD

Peter Kardos1 Group Practice and Respiratory, Allergy and Sleep Unit, Red Cross Maingau Hospital, Frankfurt, GermanyCorrespondence[email protected]
,
Sally Worsley2 GSK, Stockley Park, Middlesex
,
Dave Singh3 University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK
,
Miguel Román-Rodríguez4 Primary Care Respiratory Research Unit, Instituto de Investigación Sanitaria de Palma IdisPa, Palma de Mallorca, Spain
,
David E Newby5 BHF Centre for Cardiovascular Science, University of Edinburgh, The Queen’s Medical Research Institute, Edinburgh, UK
&
Hana Müllerová2 GSK, Stockley Park, Middlesex
Pages 2885-2895 | Published online: 25 Nov 2016

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Mario Cazzola & Paola Rogliani. (2020) Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review. Expert Review of Respiratory Medicine 14:6, pages 621-635.
Read now
Paola Rogliani, Beatrice Ludovica Ritondo, Bartolomeo Zerillo, Mario Cazzola, Maria Gabriella Matera & Luigino Calzetta. (2020) Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:2, pages 215-223.
Read now
Dave Singh. (2018) Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 19:11, pages 1279-1287.
Read now
Edward M Kerwin, Robert Tosiello, Barry Price, Shahin Sanjar & Thomas Goodin. (2018) Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2917-2929.
Read now
Peter Kardos, Ingo Mokros, Rüdiger Sauer & Claus F Vogelmeier. (2018) Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1455-1468.
Read now
Timothy E Albertson, Susan Murin, Mark E Sutter & James A Chenoweth. (2017) The Salford Lung Study: a pioneering comparative effectiveness approach to COPD and asthma in clinical trials. Pragmatic and Observational Research 8, pages 175-181.
Read now

Articles from other publishers (9)

Nawar Diar Bakerly, Kirill Nikitin, Neil G Snowise, Glenn Cardwell, Daryl Freeman, Ravijyot Saggu & Anthony De Soyza. (2022) Pragmatic randomised controlled trials in COPD and asthma: how to guide clinical practice. BMJ Open Respiratory Research 9:1, pages e001303.
Crossref
David A. Leather, Rupert Jones, Ashley Woodcock, Jørgen Vestbo, Loretta Jacques & Mike Thomas. (2020) Real-World Data and Randomised Controlled Trials: The Salford Lung Study. Advances in Therapy 37:3, pages 977-997.
Crossref
Jianchao Zhang, Junnan Tang, Xiaolin Cui, Bo Wang, Mengsen Bu, Yan Bai, Kai Wang, Jiacheng Guo, Deliang Shen & Jinying Zhang. (2019) Indirect comparison of novel Oral anticoagulants among Asians with non-Valvular atrial fibrillation in the real world setting: a network meta-analysis. BMC Cardiovascular Disorders 19:1.
Crossref
Meng-Ting Wang, Jyun-Heng Lai, Chen-Liang Tsai & Jun-Ting Liou. (2019) Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease. Journal of Food and Drug Analysis 27:3, pages 657-670.
Crossref
Fernanda S. Tonin, Laiza M. Steimbach, Leticia P. Leonart, Vinicius L. Ferreira, Helena H. Borba, Thais Piazza, Ariane G. Araújo, Fernando Fernandez-Llimos, Roberto Pontarolo & Astrid Wiens. (2018) Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 74:11, pages 1513-1521.
Crossref
Klaus F. Rabe, John R. Hurst & Samy Suissa. (2018) Cardiovascular disease and COPD: dangerous liaisons?. European Respiratory Review 27:149, pages 180057.
Crossref
Umberto Vespasiani-Gentilucci, Claudio Pedone, Moises Muley-Vilamu & Raffaele Antonelli-Incalzi. (2018) The pharmacological treatment of chronic comorbidities in COPD: mind the gap!. Pulmonary Pharmacology & Therapeutics 51, pages 48-58.
Crossref
Charles J. Vierck & C. Richard Chapman. (2018) Prospective evaluation of chronic pain disorders and treatments. Journal of Neuroscience Methods 295, pages 104-110.
Crossref
Nera Agabiti & Giuseppe Maria Corbo. (2017) COPD and bronchodilators: should the heart pay the bill for the lung?. European Respiratory Journal 49:5, pages 1700370.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.